Kaiser Permanente's New Technologies Committee: an approach to assessing technology

Area of Science:

• Medical technology assessment
• Health policy development
• Reproductive genetics

Background:

• Emerging medical technologies require rigorous evaluation for clinical integration.
• Kaiser Permanente's New Technologies Committee assesses technologies for experimental status and coverage.
• Chorionic villus sampling (CVS) is a key example of technology assessment in reproductive health.

Purpose of the Study:

• To describe Kaiser Permanente's model for evaluating and covering new medical technologies.
• To illustrate this model using the case of chorionic villus sampling.
• To highlight the process of consensus and policy formation for emerging health innovations.

Main Methods:

• Review of the New Technologies Committee's operational framework.
• Case study analysis of chorionic villus sampling adoption.
• Examination of policy development for experimental versus nonexperimental technologies.

Main Results:

• The committee systematically evaluates new technologies, determining their coverage criteria.
• A consensus-based model facilitated the integration of chorionic villus sampling.
• This process established chorionic villus sampling as a preferred alternative to amniocentesis for fetal defect detection.

Conclusions:

• Kaiser Permanente's structured approach enables effective management of emerging medical technologies.
• The model ensures evidence-based decision-making for patient care and resource allocation.
• Successful implementation of technologies like chorionic villus sampling demonstrates the model's efficacy.